AbbVie (ABBV) Prepaid Assets (2012 - 2026)
AbbVie (ABBV) posted quarterly Prepaid Assets of $6.6 billion for Q1 2026, up 20.27% year-over-year from $5.5 billion in Q1 2025, and up 5.04% quarter-over-quarter from $6.3 billion in Q4 2025.
AbbVie (ABBV) Prepaid Assets (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Prepaid Assets for 15 consecutive years, with $6.6 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 20.27% year-over-year to $6.6 billion; the TTM figure through Mar 2026 stood at $6.6 billion (up 20.27% YoY), while the FY2025 annual figure was $6.3 billion, up 27.72% from the prior year.
- Prepaid Assets advanced to $6.6 billion in Q1 2026 per ABBV's latest filing, from $6.3 billion in the prior quarter.
- Across five years, Prepaid Assets topped out at $6.6 billion in Q1 2026 and bottomed at $4.4 billion in Q4 2022.
- Historically, Prepaid Assets has averaged $5.0 billion across 5 years, with a median of $4.7 billion in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets dropped 11.86% — and 2025, when it climbed 27.72%.
- AbbVie's Prepaid Assets stood at $4.4 billion in 2022, then advanced by 12.07% to $4.9 billion in 2023, then fell by 0.1% to $4.9 billion in 2024, then climbed by 27.72% to $6.3 billion in 2025, then grew by 5.04% to $6.6 billion in 2026.
- Business Quant data shows ABBV's Prepaid Assets at $6.6 billion in Q1 2026, $6.3 billion in Q4 2025, and $5.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.15 Bn |
| Mar 31, 2026 | 6.61 Bn |
| Dec 31, 2025 | 6.29 Bn |
| Sep 30, 2025 | 5.16 Bn |
| Jun 30, 2025 | 5.20 Bn |
| Mar 31, 2025 | 5.50 Bn |
| Dec 31, 2024 | 4.93 Bn |
| Sep 30, 2024 | 4.58 Bn |
| Jun 30, 2024 | 4.72 Bn |
| Mar 31, 2024 | 4.61 Bn |
| Dec 31, 2023 | 4.93 Bn |
| Sep 30, 2023 | 4.54 Bn |
| Jun 30, 2023 | 4.54 Bn |
| Mar 31, 2023 | 4.46 Bn |
| Dec 31, 2022 | 4.40 Bn |
| Sep 30, 2022 | 4.57 Bn |
| Jun 30, 2022 | 4.51 Bn |
| Mar 31, 2022 | 4.72 Bn |
| Dec 31, 2021 | 4.99 Bn |
| Sep 30, 2021 | 4.33 Bn |